How long has tirzepatide been around? Mounjaro was FDA-approved in May 2022; Zepbound followed in 2023. Tirzepatide is a new drug with a short track record.
Tirzepatide has been available to patients in the United States since May 2022, when the FDA approved it under the brand name Mounjaro for type 2 diabetes. The molecule was first described in peer-reviewed research in 2018, and it received a second approval in November 2023 as Zepbound for chronic weight management. That makes tirzepatide a new drug — roughly three years on the U.S. market — rather than a long-established medication.
Tirzepatide Basics at a Glance
- Drug class: dual GIP and GLP-1 receptor agonist
- Manufacturer: Eli Lilly
- Brand names: Mounjaro (type 2 diabetes) and Zepbound (weight management)
- How it is taken: once-weekly subcutaneous injection
- First FDA approval: May 13, 2022
- Generic versions: none approved in the United States
A Short Timeline of Tirzepatide
Tirzepatide moved from the lab to pharmacy shelves in less than a decade, which is fast by pharmaceutical standards.
| Timeframe | Milestone |
|---|---|
| 2018 | Early published research describes the dual GIP/GLP-1 molecule and first human trial results |
| 2019–2021 | The SURPASS phase 3 program studies tirzepatide in thousands of adults with type 2 diabetes |
| May 2022 | FDA approves Mounjaro for type 2 diabetes |
| 2022 | SURMOUNT-1 results report substantial weight loss in adults with obesity |
| November 2023 | FDA approves Zepbound for chronic weight management |
| Late 2024 | FDA declares the tirzepatide shortage resolved, winding down most large-scale compounding |
How Tirzepatide's History Compares With Older Options
Tirzepatide is the newest of the major GLP-1-related drugs, and that shows up clearly when you line up approval dates side by side.
| Medication | First FDA approval | Approximate time on the U.S. market |
|---|---|---|
| Metformin (Glucophage) | 1995 | About 30 years |
| Liraglutide (Victoza) | 2010 | About 15 years |
| Semaglutide (Ozempic) | 2017 | About 8 years |
| Tirzepatide (Mounjaro) | 2022 | About 3 years |
Semaglutide, the active ingredient in Ozempic and Wegovy, reached the market about five years before tirzepatide. Metformin has been prescribed in the United States for roughly three decades. That gap matters when patients ask how much long-term safety data exists for each option.
What a Short Track Record Means for Safety
Tirzepatide's clinical program was large, but it was also compressed into a few years. Here is what is well established and what is not.
- Phase 3 trials enrolled tens of thousands of participants, producing solid short- and medium-term safety data.
- Common side effects include nausea, vomiting, diarrhea, constipation, and reduced appetite, especially during dose increases.
- The FDA label carries a boxed warning about thyroid C-cell tumors observed in rodents; it is unknown whether tirzepatide causes these tumors in humans.
- Data on use beyond a few years, during pregnancy, or in children remains limited.
Tirzepatide is not a cure for obesity or type 2 diabetes, and it is intended for use alongside diet and physical activity. Anyone considering it should review personal risks with a licensed healthcare professional.
How Long Does Tirzepatide Take to Work?
Most patients notice appetite changes within the first one to four weeks, often before the scale moves. Doses are typically raised every four weeks, reaching the maximum 15 mg dose after about 20 weeks.
Weight loss tends to build steadily and often continues for 12 to 18 months before leveling off. Blood sugar improvements in type 2 diabetes usually appear within the first few months of treatment.
How Long Does Tirzepatide Stay in Your System?
Tirzepatide has a half-life of roughly five days, which is why it is dosed once a week and why steady drug levels take about four weeks to build. After a final injection, it takes about 25 to 30 days for most of the drug to clear.
Clearing the drug does not mean the effects disappear overnight. Appetite, digestion, and blood sugar changes typically fade gradually over the following weeks, and some people regain weight after stopping.
Other "How Long" Questions in Peptide Research
Timing questions come up constantly in the peptide world, and they follow a familiar pattern of onset, duration, and clearance. People search how long does bac water last before reconstituting a vial, and researchers planning bloodwork want to know how long does ipamorelin stay in your system.
A closely related query, how long does cjc 1295 ipamorelin stay in your system, reflects the same concern about stacking and washout periods. Some also ask how long can you take cjc 1295/ipamorelin before cycling off, or type pt-141 how long does it take to work when planning a protocol.
Many of these compounds are sold as research chemicals and are not FDA-approved for human use. Talk with a healthcare professional before injecting anything that has not been prescribed for you.
Questions to Ask Your Healthcare Provider
- How long do you expect me to stay on tirzepatide?
- What monitoring do you recommend for thyroid, pancreas, and gallbladder health?
- What happens if I stop the medication?
- Are there interactions with my current prescriptions?
Tirzepatide has only been on the U.S. market since 2022, so long-term outcomes are still being tracked through registries and post-marketing studies.
Frequently Asked Questions
How long has tirzepatide been around in the United States?
Tirzepatide has been approved in the United States since May 2022, when the FDA cleared Mounjaro for type 2 diabetes. Zepbound followed in November 2023 for chronic weight management. That gives the drug roughly three years of U.S. market history, though the molecule was first described in research published in 2018.
How long does it take for tirzepatide to start working?
Most people notice appetite changes within one to four weeks of the first dose. Blood sugar improvements in type 2 diabetes usually show up within a few months, while weight loss tends to build gradually over 12 to 18 months as the dose is increased.
How long does tirzepatide stay in your system?
Tirzepatide has a half-life of about five days, so it takes roughly 25 to 30 days for most of the drug to leave the body after the last injection. Effects on appetite and blood sugar typically fade gradually over that period rather than stopping abruptly.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.